Cargando…

Severe adverse drug reaction to allopurinol

Detalles Bibliográficos
Autores principales:	Lucas, Grace, Droney, Luke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	NPS MedicineWise 2022
Materias:	Medicinal Mishap
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427627/ https://www.ncbi.nlm.nih.gov/pubmed/36110177 http://dx.doi.org/10.18773/austprescr.2022.032

Ejemplares similares

Chronic lithium toxicity
por: Reimann, Frank, et al.
Publicado: (2022)

Osteonecrosis of the jaw and denosumab
por: Goss, Alastair N
Publicado: (2022)

Iatrogenic Cushing’s syndrome with inhaled fluticasone
por: Ledger, Thomas, et al.
Publicado: (2019)

Death from diltiazem–ibrutinib interaction
por: Falconer, Nazanin, et al.
Publicado: (2021)

Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy
por: Scavone, Cristina, et al.
Publicado: (2019)

Predominant HLA Alleles and Haplotypes in Mild Adverse Drug Reactions Caused by Allopurinol in Vietnamese Patients with Gout
por: Van Son, Chu, et al.
Publicado: (2021)

Genetics of Severe Cutaneous Adverse Reactions
por: Yang, Shang-Chen, et al.
Publicado: (2021)

A prospective study of HLA*B-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions
por: Ko, Tai-Ming, et al.
Publicado: (2014)

HLA-B(*)58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand
por: Sukasem, Chonlaphat, et al.
Publicado: (2016)

Toxic Epidermal Necrolysis Caused by Allopurinol: A Serious but Still Underestimated Adverse Reaction
por: Hoyer, Daniel, et al.
Publicado: (2021)

WGCNA-Based DNA Methylation Profiling Analysis on Allopurinol-Induced Severe Cutaneous Adverse Reactions: A DNA Methylation Signature for Predisposing Drug Hypersensitivity
por: Cheng, Lin, et al.
Publicado: (2022)

Dress syndrome secondaire à l’allopurinol
por: Zemmez, Youssef, et al.
Publicado: (2018)

HLA-B*58:01 allele is strongly associated with allopurinol-induced severe cutaneous adverse reactions in a Thai population
por: Jantararoungtong, Thawinee, et al.
Publicado: (2014)

Allopurinol-Induced Oral Lichenoid Drug Reaction with Complete Regression after Drug Withdrawal
por: Perez, Alexandre, et al.
Publicado: (2020)

Unusual drug reaction with features of colchicine toxicity in a patient on colchicine and allopurinol
por: Salari, Behzad, et al.
Publicado: (2022)

Allopurinol-induced Drug Reactions with Eosinophilia and Systemic Symptoms Syndrome with Interstitial Nephritis
por: Aatif, T., et al.
Publicado: (2018)

Age-Associated Risk of Liver-Related Adverse Drug Reactions
por: Han, Yan-zhong, et al.
Publicado: (2022)

Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies
por: Wu, Ran, et al.
Publicado: (2016)

Causality, Severity, and Avoidability of Adverse Drug Reactions in Hospitalized Children: A Prospective Cohort Study
por: Gupta, Saurabh, et al.
Publicado: (2023)

Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions
por: Copaescu, Ana Maria, et al.
Publicado: (2022)

Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
por: Ko, Tai-Ming, et al.
Publicado: (2015)

Real‐world evidence of population differences in allopurinol‐related severe cutaneous adverse reactions in East Asians: A population‐based cohort study
por: Sato, Tsugumichi, et al.
Publicado: (2021)

Investigating the Anti-inflammatory Effect of Allopurinol on the Prevention of Prostate Cancer
por: Ganz, Marc, et al.
Publicado: (2023)

Comparison between the HLA-B(∗)58 : 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions
por: Saksit, Niwat, et al.
Publicado: (2017)

Cardiovascular Safety of Febuxostat and Allopurinol in Hyperuricemic Patients With or Without Gout: A Network Meta-Analysis
por: Zhang, Shengzhao, et al.
Publicado: (2021)

Allopurinol-Induced Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome: A Cause of Acalculous Cholecystitis?
por: Waseem, Husnain, et al.
Publicado: (2017)

Pustular drug hypersensitivity syndrome due to allopurinol
por: Salem, Chaker Ben, et al.
Publicado: (2015)

Validation of a Rapid, Robust, Inexpensive Screening Method for Detecting the HLA-B(*)58:01 Allele in the Prevention of Allopurinol-Induced Severe Cutaneous Adverse Reactions
por: Nguyen, Dinh Van, et al.
Publicado: (2017)

Allopurinol-induced severe cutaneous adverse reactions: A report of three cases with the HLA-B(*)58:01 allele who underwent lymphocyte activation test
por: Kim, Eun-Young, et al.
Publicado: (2017)

Sex difference in heart failure risk associated with febuxostat and allopurinol in gout patients
por: Cheng, Ching-Lan, et al.
Publicado: (2022)

The assessment of severe cutaneous adverse drug reactions
por: Copaescu, Ana M, et al.
Publicado: (2022)

Severe Adverse Drug Reaction to Gadobenate Dimeglumine
por: Singer, Benjamin D., et al.
Publicado: (2009)

Adverse Drug reactions in an Ageing PopulaTion (ADAPT) study protocol: a cross-sectional and prospective cohort study of hospital admissions related to adverse drug reactions in older patients
por: Cahir, Caitriona, et al.
Publicado: (2017)

The therapeutic concordance approach reduces adverse drug reactions in patients with resistant hypertension
por: Trimarco, Valentina, et al.
Publicado: (2023)

Allopurinol induced erythroderma
por: Sharma, Geeta, et al.
Publicado: (2013)

Allopurinol: Sorrow to the marrow
por: Raaju, UR, et al.
Publicado: (2020)

Allopurinol hypersensitivity syndrome
por: Yaseen, Wid, et al.
Publicado: (2023)

Severe Adverse Drug Reactions in Korean Elderly Patients
por: Lee, Jungun
Publicado: (2022)

Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions
por: Orime, Mari
Publicado: (2017)

Recent Advances in Severe Cutaneous Adverse Drug Reaction
por: Das, Sudip, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t6s7d56opv9qtgu7pck409tsf5